Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

TREATMENT OF CANCER WITH HUMAN CHORIONIC GONADOTROPIN

  • Read more about TREATMENT OF CANCER WITH HUMAN CHORIONIC GONADOTROPIN
US Patent 5,677,275
Filed on 1994-08-05

MULTIDETERMINANT PEPTIDE ANTIGENS THAT STIMULATE HELPER T LYMPHOCYTE RESPONSE TO HIV IN A RANGE OF HUMAN SUBJECTS

  • Read more about MULTIDETERMINANT PEPTIDE ANTIGENS THAT STIMULATE HELPER T LYMPHOCYTE RESPONSE TO HIV IN A RANGE OF HUMAN SUBJECTS
US Application 08/109,730
Filed on 1993-08-19

DNA ENCODING HUMAN AND MURINE EPS15, A SUBSTRATE FOR THE EPIDERMAL GROWTH FACTOR RECEPTOR

  • Read more about DNA ENCODING HUMAN AND MURINE EPS15, A SUBSTRATE FOR THE EPIDERMAL GROWTH FACTOR RECEPTOR
US Patent 5,487,979
Filed on 1993-07-22

HUMAN PROSTATIC CELL LINES IMMORTALIZED BY ADENOVIRUS 12-SIMIAN VIRUS 40 (AD12/SV40) HYBRID VIRUS

  • Read more about HUMAN PROSTATIC CELL LINES IMMORTALIZED BY ADENOVIRUS 12-SIMIAN VIRUS 40 (AD12/SV40) HYBRID VIRUS
US Patent 5,610,043
Filed on 1994-04-28

USE OF NITRIC OXIDE RELEASING COMPOUNDS AS HYPOXIC CELL RADIATION SENSITIZERS

  • Read more about USE OF NITRIC OXIDE RELEASING COMPOUNDS AS HYPOXIC CELL RADIATION SENSITIZERS
US Application 08/133,574
Filed on 1993-10-08

Compositions and Methods for Therapy and Prevention of Cancer, Anemia and AIDS

  • Read more about Compositions and Methods for Therapy and Prevention of Cancer, Anemia and AIDS
US Patent 6,037,376
Filed on 1991-10-21

SIGNAL TRANSDUCTION THERAPY OF ANGIOGENESIS

  • Read more about SIGNAL TRANSDUCTION THERAPY OF ANGIOGENESIS
US Application 08/123,614
Filed on 1993-09-17

Expression Vectors Able To Elicit Improved Immune Response and Methods of Using Same

  • Read more about Expression Vectors Able To Elicit Improved Immune Response and Methods of Using Same
Canada
2427257
Filed on 2001-11-01

PHOSPHONOALKYL PHENYLALANINE COMPOUNDS SUITABLY PROTECTED FOR USE IN PEPTIDE SYNTHESIS

  • Read more about PHOSPHONOALKYL PHENYLALANINE COMPOUNDS SUITABLY PROTECTED FOR USE IN PEPTIDE SYNTHESIS
US Patent 5,475,129
Filed on 1993-06-08

DNA FOR USE IN A SIMPLE METHOD FOR DETECTING INHIBITORS OF RETROTRANSPOSITION

  • Read more about DNA FOR USE IN A SIMPLE METHOD FOR DETECTING INHIBITORS OF RETROTRANSPOSITION
US Patent 5,462,873
Filed on 1993-08-06

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1597
  • Page 1598
  • Page 1599
  • Page 1600
  • Page 1601
  • Page 1602
  • Page 1603
  • Page 1604
  • Page 1605
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health